Kala Pharmaceuticals Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$121.2M
Industry:Pharma
Founded:2009
Lead Investor(s):Athyrium Capital Management
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Kala Pharmaceuticals's estimated annual revenue is currently $10.7M per year.
  • Kala Pharmaceuticals received $110.0M in venture funding in October 2018.
  • Kala Pharmaceuticals's estimated revenue per employee is $70,086
  • Kala Pharmaceuticals's total funding is $121.2M.

Employee Data

  • Kala Pharmaceuticals has 152 Employees.
  • Kala Pharmaceuticals grew their employee count by 1% last year.
  • Kala Pharmaceuticals currently has 45 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ironwood Pharma...
N/A445N/AN/A
Infinity Pharma...
N/A411N/AN/A
Karyopharm Ther...
$30.3M38550%N/A
Carna Bioscienc...
$5.4M27N/AN/A
Boston Pharmace...
$17.3M8648%N/A
Vita Data Scien...
$10.3M5150%N/A
Veristat
$51.9M25815%N/A
Radius Health
N/A453N/AN/A
Sunovion Pharma...
$546.3M2718N/AN/A
Ariad Pharmaceu...
N/A179N/AN/A
Missing a competitor? Contribute!?
Submit

Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. For more information, please visit Kala's website at www.kalarx.com.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Security,Wind Power

152

Number of Employees

$10.7M

Revenue (est)

45

Current Jobs

1%

Employee Growth %

$121.2M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Hongming ChenChief Scientific OfficerEmail Available
Kim BrazzellChief Medical Officer
Evan RosenbergAccounting ManagerEmail Available
Todd BazemoreChief Operating Officer
Mary ReumuthChief Financial Officer
Christine FiumaraTerritory Sales ManagerEmail Available
Seamus GillespieDirector Of FinanceEmail Available
Brett ObrovacTerritory Sales ManagerEmail Available
Lindy BollingTerritory Sales Manager - MichiganEmail Available
Briana FosterDirector, Commercial Learning & DevelopmentEmail Available

Kala Pharmaceuticals News

24-Aug-19 - Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kala Pharmaceuticals, Inc. (KALA), today announced that the Company granted non-statutory stock options to new employees as inducement ...

31-Aug-19 - Kala Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

Kala Pharmaceuticals, Inc. (KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its ...

12-Sep-19 - Kala Pharmaceuticals, Inc. (KALA) Quickly Moves 3.46%; May Remain in Focus Today

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is among the top stocks that may remain in focus today as the company shares are trading 3.46% ...

Kala Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2012-03-15$6.2MUndisclosedLux Capital, Polaris Venture PartnersArticle
2013-03-01$11.5MACrown Venture Fund LLCArticle
2014-04-24$22.5MBYsios CapitalArticle
2016-04-14$68.0MCLongitude CapitalArticle
2018-10-03$110.0MUndisclosedAthyrium Capital ManagementArticle

Kala Pharmaceuticals Executive Hires

DateNameTitleReference
2012-07-13Guillaume PfeferCEO/PresidentArticle
2013-03-01Kim BrazzellChief Medical OfficerArticle
2013-05-29Charles McDermottEVP Business DevelopmentArticle
2014-01-07Howard B. RosenChairmanArticle
2015-05-15Mark IwickiExecutive ChairmanArticle
2017-11-14Todd BazemoreChief Operating OfficerArticle
2018-04-04Eric TrachtenbergGeneral Counsel and Corporate Secretary.Article
2018-10-26Steven ZhangVice President of Medical AffairsArticle